Aygül Çeltik1, Sait Şen2, Mümtaz Yılmaz1, Meltem Seziş Demirci1, Gülay Aşçı1, Abdülkerim Furkan Tamer1, Banu Sarsık2, Cüneyt Hoşcoşkun3, Hüseyin Töz4, Ercan Ok1. 1. Division of Nephrology, Department of Internal Medicine, School of Medicine, Ege University, 35100, Bornova, Izmir, Turkey. 2. Department of Pathology, School of Medicine, Ege University, Bornova, Izmir, 35100, Turkey. 3. Department of General Surgery, School of Medicine, Ege University, Bornova, Izmir, 35100, Turkey. 4. Division of Nephrology, Department of Internal Medicine, School of Medicine, Ege University, 35100, Bornova, Izmir, Turkey. huseyin.toz@ege.edu.tr.
Abstract
PURPOSE: Persistent hypercalcemia after kidney transplantation (KTx) may cause nephrocalcinosis and graft dysfunction. The aim of this study was to evaluate patients with hypercalcemia and assess its effect on tubulointerstitial calcification. METHODS: A total of 247 recipients were enrolled. Transient and persistent hypercalcemia was defined as hypercalcemia (corrected serum calcium >10.2 mg/dL) persisting for 6 and 12 months after KTx, respectively. The severity of calcification in the 0-h, 6- and 12-month protocol biopsies of patients with transient (n = 8) and persistent hypercalcemia (n = 20) was compared with a matched control group (n = 28). RESULTS: Twenty-eight patients were hypercalcemic at 6 months posttransplantation. Serum calcium levels were normalized in eight of them at the end of the first year. Dialysis duration was a positive predictor of persistent hypercalcemia. Tubulointerstitial calcification was detected in 70.6 and 90 % of patients with persistent hypercalcemia at 6 and 12 months posttransplantation, respectively. In 20 % of patients with transient hypercalcemia, severity of calcification regressed at 12 months posttransplantation along with normalization of serum calcium levels. Graft functions and histopathological findings (ci, ct, ci + ct, cv, ah, percentage of sclerotic glomeruli) were not different at 6 and 12 months posttransplantation. CONCLUSIONS: Hypercalcemia and persistent hyperparathyroidism are not rare after KTx. Tubulointerstitial calcification is more common and progressive among patients with persistent hypercalcemia. Normalization of calcium levels may contribute to regression of calcification in some patients.
PURPOSE: Persistent hypercalcemia after kidney transplantation (KTx) may cause nephrocalcinosis and graft dysfunction. The aim of this study was to evaluate patients with hypercalcemia and assess its effect on tubulointerstitial calcification. METHODS: A total of 247 recipients were enrolled. Transient and persistent hypercalcemia was defined as hypercalcemia (corrected serum calcium >10.2 mg/dL) persisting for 6 and 12 months after KTx, respectively. The severity of calcification in the 0-h, 6- and 12-month protocol biopsies of patients with transient (n = 8) and persistent hypercalcemia (n = 20) was compared with a matched control group (n = 28). RESULTS: Twenty-eight patients were hypercalcemic at 6 months posttransplantation. Serum calcium levels were normalized in eight of them at the end of the first year. Dialysis duration was a positive predictor of persistent hypercalcemia. Tubulointerstitial calcification was detected in 70.6 and 90 % of patients with persistent hypercalcemia at 6 and 12 months posttransplantation, respectively. In 20 % of patients with transient hypercalcemia, severity of calcification regressed at 12 months posttransplantation along with normalization of serum calcium levels. Graft functions and histopathological findings (ci, ct, ci + ct, cv, ah, percentage of sclerotic glomeruli) were not different at 6 and 12 months posttransplantation. CONCLUSIONS:Hypercalcemia and persistent hyperparathyroidism are not rare after KTx. Tubulointerstitial calcification is more common and progressive among patients with persistent hypercalcemia. Normalization of calcium levels may contribute to regression of calcification in some patients.
Authors: Henk Boom; Marko J K Mallat; Johan W de Fijter; Leendert C Paul; Jan A Bruijn; Leendert A van Es Journal: Transplantation Date: 2004-03-27 Impact factor: 4.939
Authors: Brian J Nankivell; Richard J Borrows; Caroline L-S Fung; Philip J O'Connell; Richard D M Allen; Jeremy R Chapman Journal: N Engl J Med Date: 2003-12-11 Impact factor: 91.245
Authors: Sandra Habbig; Bodo B Beck; Markus Feldkötter; Friederike Körber; Charlie Laffeber; Carl Verkoelen; Michael J Mihatsch; Bernd Hoppe Journal: Am J Nephrol Date: 2009-04-30 Impact factor: 3.754
Authors: A Sewpaul; J A Sayer; M A S Mohamed; A Ahmed; M Shaw; V R Prabhu; K Wood; N A Jones; D Talbot; N S Kanagasundaram Journal: Clin Nephrol Date: 2007-07 Impact factor: 0.975
Authors: Juan C Ramirez-Sandoval; Pablo Diener-Cabieses; Fabián Gutiérrez-Valle; Sofía Ley-Tapia; Santiago Pastrana-Brandes; Pablo E Galindo; Reynerio Fagundo; Mauricio Moreno-Yañez; Alfredo Adolfo Reza-Albarrán; Ricardo Correa-Rotter Journal: Int Urol Nephrol Date: 2022-03-16 Impact factor: 2.266